Literature DB >> 2009318

Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage.

O Amellem1, E O Pettersen.   

Abstract

Cycling mammalian cells that are rendered extremely hypoxic (less than 4 ppm O2) tend to accumulate in a pre-DNA-synthesis stage. It is not clear whether or not this is the result of an active regulation by the cells. In the present study we have rendered cells, synchronized by mitotic selection, extremely hypoxic over a relatively long period of time (up to 48 h). We have recorded cell cycle progression during hypoxia as well as cell inactivation depending on where in the cell cycle the cells were located when the hypoxic treatment was started. Three main conclusions are drawn: 1 the cell cycle arrest in late-G1 is complete even during a long-lasting (24 h) hypoxic treatment: 2 while cells in early- and mid-S are completely arrested and quickly inactivated under hypoxic conditions, cells in late-S, G2 and mitosis are able to continue cell cycle progression and divide; 3 whether the cells are located in G2, mitosis or early-G1 at the onset of hypoxia, they were able to survive relatively long-lasting hypoxic treatment. The present results are in favour of the view that the pre-DNA-synthetic arrest induced by extreme hypoxia may function to rescue the cells from severely damaging effects that would appear if the cells were able to initiate DNA synthesis.

Entities:  

Mesh:

Year:  1991        PMID: 2009318     DOI: 10.1111/j.1365-2184.1991.tb01144.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  19 in total

1.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

Review 2.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Authors:  Y Waerzeggers; R T Ullrich; P Monfared; T Viel; M Weckesser; W Stummer; O Schober; A Winkeler; A H Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Oxygen deprivation causes suspended animation in the zebrafish embryo.

Authors:  P A Padilla; M B Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  Hypoxia-Inducible Factors and Cancer.

Authors:  Jonathan C Jun; Aman Rathore; Haris Younas; Daniele Gilkes; Vsevolod Y Polotsky
Journal:  Curr Sleep Med Rep       Date:  2017-01-28

5.  Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia.

Authors:  Kenneth J D Lang; Andreas Kappel; Gregory J Goodall
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

6.  Identification of a novel small molecule HIF-1alpha translation inhibitor.

Authors:  Takuhito Narita; Shaoman Yin; Christine F Gelin; Carlos S Moreno; Manuel Yepes; K C Nicolaou; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

7.  Counteraction of pRb-dependent protection after extreme hypoxia by elevated ribonucleotide reductase.

Authors:  P Graff; J Seim; Ø Amellem; H Arakawa; Y Nakamura; K K Andersson; T Stokke; E O Pettersen
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

Review 8.  Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.

Authors:  Ameya R Kirtane; Stephen M Kalscheuer; Jayanth Panyam
Journal:  Adv Drug Deliv Rev       Date:  2013-09-10       Impact factor: 15.470

9.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Authors:  T G Graeber; J F Peterson; M Tsai; K Monica; A J Fornace; A J Giaccia
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia.

Authors:  O Thews; T Wolloscheck; W Dillenburg; S Kraus; D K Kelleher; M A Konerding; P Vaupel
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.